13-Employee SoCal Startup Bioniz Has A $400 Million Valuation Post author:Sam Post published:December 19, 2017 Post category:BioPharma Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace You Might Also Like Pfizer Terminates PDC Agreement with CytomX Therapeutics March 7, 2018 Asklepios BioPharma Launches New Biotech Actus Therapeutics December 14, 2017 Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug August 6, 2017
